(Q38104568)

28 August 2017

title

Taxane benefit in breast cancer--a role for grade and chromosomal stability (English)

1 reference

28 August 2017

Charles Swanton

7

0 references

Jorge Reis-Filho

5

object named as

Jorge S Reis-Filho

1 reference

28 August 2017

Roger P A'Hern

1

1 reference

28 August 2017

Mariam Jamal-Hanjani

2

1 reference

28 August 2017

A Marcell Szász

3

1 reference

28 August 2017

Stephen R D Johnston

4

1 reference

28 August 2017

Rebecca Roylance

6

1 reference

28 August 2017

language of work or name

English

0 references

publication date

7 May 2013

1 reference

Nature Reviews Clinical Oncology

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

357-364

1 reference

Cancer chromosomal instability: therapeutic and diagnostic challenges

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Replication stress links structural and numerical cancer chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Breast cancer prognostic classification in the molecular era: the role of histological grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Chromosomal instability determines taxane response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Epothilones and new analogues of the microtubule modulators in taxane-resistant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Mutations of mitotic checkpoint genes in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Chromosomal instability, colorectal cancer and taxane resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Improved grading of breast adenocarcinomas based on genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Genetic instability and darwinian selection in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Karyotypic "state" as a potential determinant for anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Targeting cancer cells by exploiting karyotypic complexity and chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Centrosome amplification drives chromosomal instability in breast tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Defining 'chromosomal instability'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

A systematic review of taxane-containing regimens for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Chromosome instability and deregulated proliferation: an unavoidable duo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Paradoxical relationship between chromosomal instability and survival outcome in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Methodological and practical challenges for personalized cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Challenges translating breast cancer gene signatures into the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Prognostic significance of DNA measurements in 409 consecutive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The new cytogenetics: blurring the boundaries with molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Analysis of cellular DNA content by flow and laser scanning cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Array comparative genomic hybridization and its applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: correlation with cytologic grading

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Correlation of numerical and structural status of chromosome 16 with histological type and grade of non-invasive and invasive breast carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

The 2011 EBCTCG polychemotherapy overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Histological grade in breast cancer: association with clinical and biological features in a series of 229 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Progression of mammary adenocarcinomas as reflected by nuclear DNA content

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.67

Chromosome-specific aneusomy in carcinoma of the breast

31 March 2020

1 reference

12 December 2020

p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest.

1 reference

12 December 2020

Karyotypic complexity of the NCI-60 drug-screening panel.

1 reference

12 December 2020

The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy

1 reference

12 December 2020

DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors

1 reference

12 December 2020

S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study

1 reference

12 December 2020

DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer

1 reference

12 December 2020

10.1038/NRCLINONC.2013.67

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1023163115

0 references

1 reference